Studies of gut mucosal protein synthesis in a non-steroidal anti-inflammatory drug (NSAID) model of inflammatory bowel disease
- PMID: 1371760
- PMCID: PMC1373937
- DOI: 10.1136/gut.33.2.242
Studies of gut mucosal protein synthesis in a non-steroidal anti-inflammatory drug (NSAID) model of inflammatory bowel disease
Abstract
The extent to which defects in protein synthesis occurred in an experimental indomethacin induced rat model of nonsteroidal enteropathy has been examined. Male rats (nine) were fed indomethacin (8 mg/kg/day) for three days mixed with a powdered form of chow. The control group of rats (nine) were fed the same diet for three days without indomethacin. After the feeding period, both groups were fed a normal solid diet for four days. At the end of this period, the fractional rates of intestinal protein synthesis was determined by the 'flooding dose' technique. The mucosal protein, RNA and DNA contents in the proximal ileum of animals with enteropathy were not significantly different from controls (p greater than 0.05). Experimental enteropathy induced selective increases in the fractional rates of protein synthesis (26% increase, p less than 0.03) and RNA activities (23% increase, p less than 0.04). There were no significant changes in any of these variables in the duodenum (p greater than 0.05 in all instances). These changes may partly reflect the activity of those processes responsible for the pathogenic changes in NSAID enteropathy.
Similar articles
-
Gut protein synthetic studies in a NSAID model of inflammatory bowel disease (IBD).Biochem Soc Trans. 1991 Apr;19(2):186S. doi: 10.1042/bst019186s. Biochem Soc Trans. 1991. PMID: 1889569 No abstract available.
-
Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.Gut. 1990 Dec;31(12):1358-64. doi: 10.1136/gut.31.12.1358. Gut. 1990. Retraction in: Gut. 2001 Mar;48(3):286. PMID: 1979954 Free PMC article. Retracted.
-
Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity.J Gastroenterol Hepatol. 2017 Nov;32(11):1839-1845. doi: 10.1111/jgh.13785. J Gastroenterol Hepatol. 2017. PMID: 28295549
-
FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.Dig Dis Sci. 2017 Aug;62(8):1944-1952. doi: 10.1007/s10620-017-4600-4. Epub 2017 May 18. Dig Dis Sci. 2017. PMID: 28523577 Free PMC article.
-
Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview.Gut. 1989 Nov;30 Spec No(Spec No):22-8. doi: 10.1136/gut.30.spec_no.22. Gut. 1989. PMID: 2691345 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources